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Upon study of the calf afflicted with the weak calf syndrome, the
absence of a normal thymus development was observed. It was also
observed that weak syndrome calves could not elicit a delayed
hypersensitivity skin reaction to purified protein derivative of
tuberculin even after repeated injections of Mycobacterium bovis
strain BGG. The absence of delayed hypersensitivity was hypothesised
to be a result of a depressed or absent thymic lymphocyte (T-cell)
population. Since neonatal thymectomized mice given thymosin were
able to reconstitute a functional T-cell population, thymosin was
believed to have a similar effect on weak syndrome calves. More
specifically, the immunocompetence of the peripheral T-cell
population in weak syndrome calves was monitored to determine
if administration of thymosin reconstituted the T-cell
population. The immunocompetence of the peripheral T-cell popu
lation in weak syndrome and normal calves was determined before
administration of thymosin.
Uptake of tritiated thymodine by phytohemagglutinin (PHA) was used to
monitor the immunocompetence of the peripheral T-cell population, This
type of assay measures the stimulatory effect of the non-specific mitogen
PHA on the T-cell population which can be used to determine the
Whole blood was
immuneompetence of this lymphocyte population.
used for the blastogenesis cultures since the physical separation
of peripheral lymphocytes could not be attained in calf peripheral
blood samples. The immunocompetence of the T-cell population was
determined prior to and after one injection of thymosin (1000 jigm).
Both weak syndrome and normal calves of varying ages were used. To
determine if thymosin would increase the number of lymphocytes in the
peripheral blood, total and differential WBC counts were performed
at the time blastogenesis cultures were done.
It was determined that the T-cells from weak syndrome calves would take
up a significantly lower amount of radioactive thymidine than the
T-cells from normal calves. After administration of thymosin there was
no significant difference in the amount of tritiated thymidine uptake
between the T-cells from both calf groups. Any increase in the total
lymphocytes after thymosin was not large enough to account for the
increased stimulatory effect seen in T-cells from weak syndrome calves.
Therefore, it was hypothesised that thymosin induced the maturation
of peripheral T-cells in weak syndrome calves. An added effect of
administration of thymosin which was not fully understood was the very
rapid improvement in the general health of weak syndrome calves after
one injection of thymosin.
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Chapter 1
INTRODUCTION

Experimental work done prior to 1961 failed to establish the
immunological function of the thymus. Thymectomies performed on a
variety of adult animals resulted in little or no significant effect
on antibody production.

However, thymectomies performed on neonatal

mice (4?) and rabbits (l) resulted in a marked depletion of circulating
lymphocytes.

Further experiments showed that this procedure resulted

in decreased antibody to some antigens, and failure to reject skin
grafts.

Currently the thymus is believed to be the organ in which

immunocompetent thymic lymphocytes are produced or are induced to
differentiate.

These thymic lymphocytes migrate to peripheral lymphoid

tissue where they function as effector cells of cell-mediated immunity
and helper cells in the antibody response to some antigens.

With the

isolation and purification of thymic extracts, some workers (29» 8l)
attributed an endocrine function to the thymus.
The thymus is the first lymphoid organ to develop (31).

Within

the thymus one of the two classes of lymphocytes that are known today
develops into mature immunocompetent cells.

These thymic lymphocytes

migrate to the interfollicular and deep cortical areas of lymph nodes
and the periarteriolar areas of the white pulp in the spleen.

The

thymic lymphocytes (T-cells) can be differentiated from the thymic
independent lymphocytes (B-cells) on the basis of surface antigens,
1
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immune functions, and activity associated with mitogenic substances.
A comparison between T-cells and B-cells is provided in table 1.

At

about the onset of puberty, the thymus begins to involute (?) and
becomes smaller that it was at birth (3l).
On the basis of structure and function, Clark (13) has divided the
thymus into four distinct regions*

(l) the outermost subcapsular

cortex where large lymphocytes proliferate to produce new T-cells,
(2) the inner-cortex into which newly produced T-cells migrate, (3) the
medullar proper contained within the thymic parachyma where mature
T-cells collect, and (4) the perivascular connective tissue space.
The composition of the framework is anastomosing trabeculae of epithe
lial cells accompanied by a well defined basement membrane (30).
Histologically, the cellular contents of the thymus include epithelial
and mesenchymal reticular cells, small, medium and large lymphocytes,
macrophages, medullary inclusion cells and fibroblasts (?0, 71). Some
epithelial stroma cells in the medulla develop into Hassall's
corpuscles which are characteristic of the thymus.
In mammals the thymus develops embryologically from the third
and fourth pharyngeal pouches.

The epithelial buds of ectoderm and

endoderm grow out, pinch off and migrate to the midline of the upper
thorax (50).

After the epithelial structures have developed, the

thymus is infiltrated with precursor lymphocytes or stem cells.

The

derivation of these precursor lymphocytes is still controversial. Some
believe that these lymphocytes are of mesenchymal origin and invade the
gland secondarily from the embryonic yolk sac or liver of the fetus and
the adult bone marrow after the entrance of blood vessels and connective

Table 1

Comparison of B and T lymphocytes (21)

Properties

B-cells

T-cells

Differentiation

Bursa of Fabricius
(in birds) or as
yet unknown in
mammals

Thymus

Ag-binding receptors
on cell surface

Abundant Igs

Nature of specific
receptors is uncer
tain

Cell surface
antigens
9
TL
Ly
PC
H-2 transplantation
Approximate frequency {%)
Blood
lymph (thoracic duct)
Lymph node
Spleen
Bone marrow
Thymus
Functions
Secretion of antibody molecules
Helper function
Effector cell of cellmediated immunity
Distribution in lymph
nodes and spleen

Mitogenlc substances
PHA
Con A
FWM
LPS

+
+
+
+
*

15
10
15
35
Abundant
Rare

85
90
85
65
Few
Abundant

yes

no

no

yes

no

yes

Clustered in follicles
around germinal
centers

no
no
yes
yes

In interfollicular
areas

yes
yes
no
no

tissue into the thymus (50).

The second viewpoint is that the precur

sor thymic lymphocytes are derived by direct transformation of epithe
lium cells within the thymic rudiment and are of ectoderm-endodermal
origin (74).
The precursor stem cells migrate into the subcapsular cortex of
the thymus and become lymphoblasts.

As these lymphoblasts move from

the subcapsular cortex, through the inner-cortex, toward the thymus
medulla, they decrease in size. Prom the cortical area small immuno
competent thymic lymphocytes enter the circulation of the blood and
thoracic lymph duct migrating to the spleen and lymph nodes.
The maturation of T-cells involves specific changes in mitotic
activity and cell surface antigens (52, 6l, 80).

The large and medium

lymphoblasts, which compose about 10% of the thymus lymphocyte popula
tion, can be separated from small, nondividing lymphocytes by density
gradient centrifugation.

Using this technique, it has been shown that

thymic lymphocyte immune functions are not developed until the small or
medium lymphocytes are formed (86) and that the thymic lymphocyte
found in the lymph nodes and spleen is similar to the small and medium
lymphocyte of the thymus (15, l6).

During these experiments many small

lymphocytes were noted within the thymus.

Some of these small lymphocytes

were not immunocompetent and did not have the same surface antigens as
the peripheral thymic lymphocytes.

These cells were considered either

to be dead-end lymphocytes or a separate subpopulation of thymic
lymphocytes.
On the basis of surface antigens, the lymphocytes of the thymus
can be divided into two groups.

The largest group, about 85$ in the
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mouse strain studied, has the TL antigen, high levels of theta antigen
and low levels of H-2. The antigenic properties of the smaller
population are similar to those of peripheral thymic lymphocytes.

These

are the absence of TL antigen, low levels of theta and high levels of
H-2 antigens (68), suggesting the presence of small lymphocyte subpopulations with different activities.

Further evidence for this is that

the thymic lymphocytes involved in the graft-vs-host reaction and
tumor graft rejection are morphologically different (46).
With the more complete understanding of developmental processes
of a competent immune system, some of the immunological deficiency
diseases can be explained.

The failure of the third and fourth

pharyngeal pouches to undergo differentiation necessary to form the
thymus is an example of the classic condition known as DiGeorge's
syndrome (24, 43).

The T-cell population is virtually absent while

the B-cell line development is not impaired and functions normally,
except where helper T-cell activities are required (18). Transplanta
tion of fetal thymus tissue into patients with this syndrome has
produced a correction of T-cell and cell-mediated immunity (3i 4, 14).
In addition to the thymic aplasia seen in DiGeorge,s syndrome, some
infants with thymic dysplasia have isolated T-cell deficiencies.

The

thymus is small and consists almost entirely of epithelial cells with
no Hassall's corpuscles (18).
A similar athymic condition has been described in "nude" mice (54).
A rudimentary nonfunctional thymus which will not support thymic lympho
cytes has been found in these mice and, therefore, these mice have
a depressed population of thymic lymphocytes (22, 84).

Although there

6
Is a population of theta-bearing lymphocytes, these mice have been
generally used to study immunological processes in which the T-cell
does not partake (62, 63).

These mice are highly susceptible to

infections, have a retarded or runted growth and exhibit a wasting
syndrome if kept in a conventional environment (65).

Some endocrine

functions of the nude mice have been found to be abnormal suggesting
an interrelationship between the thymus and other endocrine glands (7).
An artifically induced situation similar to nude mice is seen when
neonatal animals are thymectomized.

When thymectomies are performed

during the neonatal stage mice develop a wasting syndrome with an
arrest of development and eventual degeneration of thymic dependent
lymphoid tissue and depression of cell-mediated immunity (46).
Thymectomies In adult animals result In a gradual loss of circulating
immunocompetent lymphocytes without the rapid development of a wasting
syndrome (48).

This would suggest that the thymus is a very important

organ in the development and maintenance of a competent immune system.
In addition to the syndromes mentioned above, several viral infec
tions of fetal and neonatal animals have deleterious effects upon the
thymus and, in turn, the immune system.

When reovirus type 3 is used

to inject neonatal mice, a very severe disease develops and only 1% of
mice survive the acute stage of the infection (85).

Those mice that

survive the acute stages show the wasting syndrome (73) and frequently
manifest lymphomas (38, 56)•

The involuted thymus noted at necropsy

could have been a direct result of the infection or an indirect result
of stress.

A depression of cell-mediated immunity has been found

in children Infected with measles virus as a result of a loss of
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cellularity of the thymic cortex (82).

An agent, possibly a herpes

virus, that produces an acute massive necrosis of the medulla and
cortex of the thymus has been isolated from mice (55» 6*0.
Although the immunobiological effects of the thymus seem quite
clear, the relation of this gland to the endocrine glands is still
unclear (29» 8l). In studying the anterior hypophysis of thymectomized
mice, Pierpaoli and Sorkin (8, 58) found degranulation and hypertrophy
of the acidophilic cells of this endocrine gland.

In mice the involu

tion and atrophy of the thymus occurred when growth hormone production
was curtailed (59).

This effect has also been demonstrated in rats (17).

Sexual maturation and onset of puberty of female mice can be delayed
when mice are thymectomized (7).

Pierpaoli and Besedosky (57) found

that newborn athymic "nude" mice acquired the capacity to reject skin
grafts following passive transfer of immunocompetent lymphocytes.
However, this therapy did not result in alleviating the retarded growth,
changes in blood levels of thyroxine or delayed onset of puberty
ordinarily noted in "nude" female mice. These investigators (57)
hypothesize that the effects of the thymus on the thyroid, adrenal
and ovaries may be a result of thymus involvement in some functions
of the brain and in the programming of certain endocrine functions
exerted during fetal and perinatal life.
Several different extracts of the thymus have been prepared.
Table 2 lists some of the extracts, molecular weight, biochemical make
up and the principle biological effect attributed to each extract.
The protein thymic extract, thymosin, isolated by Goldstein and
White (27, 28) has been studied more thoroughly than the other extracts.
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Administration of this extract has resulted in reconstitution of the
impaired immunological response in X-irradiated mice (26), neonatal
thymectomized mice (42), and in New Zealand mice which have immunol
ogical abnormalities (25).

Thymosin reconstitutes the capacity of

spleen cells from congenitally thymusless "nude" mice to evoke an
in vitro graft-vs-host response (44). Thymosin reduces the wasting
syndrome in neonatal thymectomized mice (2) and causes an acceleration
of allograft rejection (32) as well as resistance to murine sarcoma
virus induced tumors (88) and Dunnings leukemia in mice (39).

Table 2 Thymic extracts

Extract

Molecular
weight

Thymosin (27)

Thymoprotein
I & II (30)
Lymphocyte
stimulating
hormone (45)
LSHh
LSHp
Thymosterin (60)

12,000

7000

Biochemical
nature

Biological
attributes

protein

reconstitutes
cellular
immunity

polypeptide

T-cell differ
entiation

protein

WBC differen
tiation &
antibody
production

steroid

Antiprolifera
tive activity
& increases
antibody
production

15,000
80,000

Recently thymosin has been used in a child with a deficient cellmediated immune system (78). The patient had thymic hypoplasia and
abnormal immunoglobulin synthesis with a depressed percentage of T-cell
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rosettes.

Although the patient had sepsis caused by Candida albicans

during infancy, ahe was unable to elicit delayed hypersensitivity
skin tests to mumps virus, C. albicans or purified protein derivative
to tuberculin.

Thymosin therapy was instituted after it was shown

that In vitro incubation of her lymphocytes with thymosin increased the
percentage of T-cell rosettes.

During the course of treatment, which

involved 23 intramuscular injections of 1 mg per kilogram per day of
thymosin, the percentage of T-cell rosettes gradually increased to
normal, and positive delayed hypersensitivity skin test developed.

A

recent report of the patient's course showed that there was an Increased
number of total lymphocytes and percentage of spontaneous T-cell
rosette formation.

Positive delayed hypersensitivity responses have

been maintained for one and one-half years, and there was an increased
immunoglobulin G and M levels.

However, the patient's in vitro

lymphocyte response to phytohemagglutinin (PHA) and mixed lymphocyte
culture remained markedly depressed (77).
The in vitro effects of thymosin studied so fax have been the
ability of the preparation to stimulate the unmasking of T-cell
markers on precursor cells (kO, kl) and to confer on precursor cells
the sensitivity to azothioprine, anti-lymphocyte serum and antl-theta
serum (5). The mechanism of action for unmasking of T-cell markers
by thymosin has not been completely elucidated, but it is believed to
be mediated by cyclic nucleotides (67).

It can be seen that the

immunological properties attributed to the thymus can be reconstituted
by the administration of the thymic extract thymosin.

As of this date

the endocrinological effects of thymosin have not been studied.
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The basic concept of the Immune response can be applied to
cattle even though most work has been done on other mammalian models.
The first circulating lymphocytes appear at the 60th day of gestation
in cattle (?2).

Although the calf is hypogammaglobulinemia in utero

due to the lack of transplacental transfer of maternal immunoglobulins.
The bovine fetus is capable of producing antibodies as early as the
l64th day of gestation (83).

Most calves surviving intrauterine

infection with bovine viral diarrhea virus (BVD) have been found to be
producing the specific Immunoglobulin prior to birth (10,12). The rise
in concentration of 11 ^-hydroxycorticosteroid from th 20th day prior
to parturition in the fetal blood probably accounts for the depressed
T-cell response to mitotic stimulation (51).

With this depression of

the neonatal calf's immune system, it is believed that the high
concentration of maternal immunoglobulins in colostrom enhances the
ability of these calves to resist infection (51).

As the calf becomes

older the peripheral thymic lymphocytes become responsive to mitotic
stimulation with PHA (^9).
During the study of the "weak calf" syndrome of western Montana,
it became apparent that the cell-mediated immunity of a large number of
afflicted calves was depressed.

Many of those surviving the initial

delayed hypersensitivity reaction to protein derivative of tuberculin
or extracts of BGG (?5»79).

Serum immunoglobulin M and immunoglobulin G

concentrations of precolostral calves afflicted with the weak calf
syndrome and normal calves are not significantly different (3^).
Although

the etiological agent has not been identified, a viral agent

which will transform tissue cultures has been repeatedly isolated from
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infected kidney and salivary glands of afflicted calves (35.36).
Recently an experimental infection with a clinical isolate of bovine
adenovirus type 5 Induced lesions closely resembling those seen in
naturally occurring weak calf syndrome (19,20).

Upon necropsy of

aborted calves or those succumbing to the infection soon after birth,
the thymus gland was noted to be severely involuted or absent (53).
The glands, when present, weighed only one-tenth that of normal animals
of comparable age (79). Severe leukopenia with an average WBC of
1 x 103 WBC/mm3 was characteristically measured in comparison to
2.2 x lO4 WBC/mm3 counted in normal calves.

The depression was only

transitory since a leukocytosis was generally detected from about the
4th day.

A normal observation in these calves was their inability

or unwillingness to nurse.

Therefore, death was frequently directly

attributed to dehydration.

In past years only whole immune serum has

been helpful as supportive therapy.

The calves appeaxed not to

respond directly to antibiotic therapy although the reduction of
secondary bacterial infections was probably a beneficial consequence.
Several calves given the whole immune

serum lived for more than a year,

but these calves were runted and failed to gain any appreciable weight
or attain the size of normal animals in spite of being provided adequate
and ample feed.

These calves could not elicit a delayed hypersensitivity

reaction even when injected with two doses of the Paris strain of BGG
grown in the laboratory and later challenged with BCG extracts.

It

was surmised from the above data that although the calves were able
to survive with the therapeutic treatment used, their thymus gland
was severely affected by the initial in utero infection causing a
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depression in the cell-mediated immunity and possibly resulting in the
runting observed.

Statement of the problem
With the involvement of the thymus, these calves manifest a syndrome
that resembles very closely the "wasting" syndrome seen in mice
thymectomized neonately.

Since this "wasting" syndrome in mice has

been reversed by the administration of the thymic extract thymosin (42),
this study was undertaken to determine whether the administration of
thymosin to the "weak syndrome" calves could elicit similar responses.
The study, however, was limited to the in vitro effects of the thymic
extract of the T-cell population.

Chapter 2
MATERIALS AND METHODS

Processing of thymic extract
Thymosin was extracted from bovine thymus glands by a modifica
tion of Goldstein and White's method (2?).
were obtained from a local abattoir.

Frozen bovine thymus glands

The glands were cut into small

pieces and processed as follows:
1.

Homogenize thymus glands in Waring blender with 0.85$ NaCl.

2.

Centrifuge the blended mixture in 250 ml plastic centrifuge

bottles at 3.500 x G in a Universal centrifuge for 5 minutes at h° C.
3.

Remove the fluid and place 300 ml in a 500 ml glass flask.

The

flask is then placed in an 80° C water bath for 15 minutes.
k.

Gentrifuge the fluid at 3»500 x G in a Universal centrifuge for

5 minutes and remove the clear fluid.
5.

Centrifuge the clear fluid at 16,000 rpm for one hour and retain

the supernatant and discard the precipitate.
6. Precipitate with acetone at -k° C.

The clear supernatant is

added to 10 volumes of cold acetone with constant stirring.

A

precipitate forms and coaleses following stirring for 5 minutes.
7.

Place the precipitate in an evaporating dish overnight in the

cold room.
8.

Resuspend the dried precipitate in 0.1 M phosphate buffer (pH 7.2)

by constant stirring for three hours.
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Centrifuge at 3»500 x G and

14
save supernatant.
9.

A second precipitation is accomplished with saturated ammonium

sulfate, (NH^gSO^.

Add the (NH/^SO^ to the supernatant until a

final concentration of $0^5 is attained.
at ambient temperatures.

This precipitation is done

Centrifuge the mixture and save the preci

pitate.
10.

Suspend the precipitate in distilled water and dialize over

night against two changes of distilled water.
11.

Lyophilize the suspension.

A fluffy white to whitish-brown

powder is obtained with completion of the procedure.
Although chemical and physical analyses were not performed using
this material extracted from the thymus glands, the extract will be
referred to as "thymosin" throughout the text.

Administration of extracts
For injection into calves the lyophilized thymosin was suspended
in sterile 0.1 M phosphate buffer or peanut oil.

The extract was

sterilized by placing under an ultraviolet lamp for at least three
hours.

The appropriate weights of thymic extract were suspended in

the diluent to give a final concentration of 100 jugm/ml or 25,000
^igm/ml.

Bovine serum albumin (BSA) was suspended in 0.1 M phosphate

buffer to be used as a control- Dr. J. K. Ward, a Hamilton veterin
arian administered the materials to all calves.

Collection of blood samples
Venous blood samples were collected by Dr. Ward from calves.
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Blood was collected prior to any Injection to establish baseline
values and at selected intervals after the administration of test
materials the calves were bled again.

Preservative-free heparin In

concentration of 50 units/ml of blood was added at the time the blood
was drawn.

The blood was kept at ambient temperature during trans

portation, or for approximately four hours.

White blood cell (WBC)

counts were done with a Coulter Counter (Model ZBI). At this time two
blood smears were made for differential WBG counts

and serum was

collected for later analysis.

Blastogenesls cultures
Problems, which are explained later, in separation of peripheral
calf lymphocytes from erythrocytes required the use of whole peripheral
blood cultures (PBC) for blastogenesis studies (6,^9).
The peripheral blood cultures were prepared in tissue culture
medium composed of RPMI 1640 (Difco), table 3» with 10% fetal calf
serum (Microbiological Associates) and 2% Hepes buffer (Difco).
A flow chart outlining the procedure is provided in figure 1.
Briefly, a volume of whole blood was suspended in 30 ml of tissue
culture medium to give a final concentration of 1 x 10^ WBC/ml.
The medium suspension was mixed thoroughly to insure an equal distri
bution of cells. Triplicate control samples of 1.0 ml each were
removed and placed into glass tissue culture tubes prior to the
addition of phytbhemagglutinin-P (PHA-P).

Next, the concentration of

PHA-P to be used was added to the stock suspension of blood culture;
triplicate samples of 1.0 ml each were placed in glass tissue culture
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Table 3

Preparation of medium and stock solutions

RFMI 1640
Triple distilled water

1.0 liter

RPMI 1640 dry powder (Difco)

6.5 g»

Penicillin G

1000 units

Streptomycin sulfate

1000 ^igm

NaHCO^

.. 1.5 gm

Fetal calf serum, inactivated at 56° C for
30 minutes (Microbiological Associates).... 100 ml
Hepes buffer, 1.0 molar (Gibco)

20 ml

The medium was filter sterilized prior to the addition of serum
and Hepes buffer. When all materials had been added together,
the medium was stored at 4° C until used.

Tritiated thymidine stock solution
Thymidine, Methyl-^H, ImCi, Specific activity
71.5 Ci/mmole (ICN)
1 ml
RPMI 1640 with 10# fetal calf serum

99 ml

Solution at concentration of 10 jxCl/ml was stored at 4° C in a
serum bottle.

Stock PHA-P solution
PHA-P (Difco)

1 ml

RPKI 1640 with 10% fetal calf serum

9 ml

Solution stored in a calibrated dropper bottle (0.05 ml/drop)
at -70° G.
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Figure 1

Flow chart of procedures for preparation of blastogenesis
cultures from peripheral blood samples

Suspend enough peripheral blood in 30 ml of RPMI 1640 to give a final
concentration of 1 x 10" cells/ml.

Withdraw triplicate 1-ml samples
for no PHA-P control cultures.

To 20 ml of original solution add 0.1 ml of stock PHA-P (100 jil/ml),
table 3, solution - final concentration of PHA-P is 0.5jil/ml.

•

Withdraw triplicate 1-ml samples
for 0.5>il/ml PHA-P cultures.

To 10 ml of the above solution add 0.05 ml of stock PHA-P solution final concentration of PHA-P is 1.0 ^l/ml.

^

Withdraw triplicate 1-ml samples
for 1.0 ^il/ml PHA-P cultures.

To 5 ml of the above solution add 0.45 ml of stock PHA-P solution final concentration of PHA-P is 10 pl/ml.

Withdraw triplicate^.-ml samples for 10 jil/val PHA-P cultures.

Incubate at 36° C and 5% CO2 for 72 hours before addition of Q.l ml
of stock tritlated thymidine (10 jiCi/ml) to each culture - final
concentration of tritiated thymidine is 1 uCi per culture.

I

Incubate at 36° and 5% CO2 for an additional 24 hours before termina
tion of incubation period by placing the cultures in a cold room at 4° G.
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tubes.

The concentrations of 0.5 ;ul/ml, 1.0 >»l/ml and 10 jud/ml of

PHA-P Here used in the initial experiments, but when the 10 yul/ml
of PHA-P was found to inhibitory to the mitotic activity, this
concentration was abandoned.

The cultures were incubated at 36° C

and in 5% CO2 in a gas chamber.

After incubation for 72 hours, the

tritiated thymidine (ICN) was added.

A 0.1 ml volume of the stock

tritiated thymidine (specific activity 71.5 Ci/mmole) was added to
each culture tube. The mitotic activity was terminated 24 hours
after the addition of tritiated thymidine by placing the cultures
in a cold room at 4° C. The cultures were then processed for counting
by liquid scintillation.

Processing of radioactive samples
When the blastogenesls samples were ready for counting, each suspen
sion was processed following the procedure outlines in figure 2.

The

technique used involved collecting the incorporated radioactive
thymidine on a filter paper. The cells were collected on Whatman GF/C
filter paper.

Red blood cells were lysed and all debris washed through

with cold Jfo acetic acid.

The cellular nucleic acids were precipitated

with 10/S trichloracetic acid and the filter papers were dried in an
oven at 65° C prior to the addition of the scintillation fluor. The
waste fluid collected in the vacuum container was disposed in a
receptacle for radioactive liquid waste.

After the filter papers

had dried, a volume of 10 ml of scintillation fluor was added to
each vial containing a single filter paper. The sample vials were
counted for ten minutes in a Nuclear Chicago Unilux III liquid
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Figure 2

Flow chart Indicating processing procedures for trltlated
thymidine labeled lymphocyte* from PHA stimulated
blastogenesis cultures

Pour contents of test tube into filtering well which contains a damp
Whatman GF/C filter.

t
Rinse tube with k ml of cold (4° C) 3% acetic acid and pour contents
of tube into filtering well.

J

Turn on vacuum and suction contents of well through the filter.

I

Release vacuum and add 1 ml of cold (4° C) 10% trichloroacetic acid
to the filtering well. Allow to stand for 30-40 seconds. Suction
contents of well through filter.

I

Wash the filter with 3 ml of cold phosphate buffered saline (pH 7.2).

T
Transfer filter to scintillation vial.

1

Dry the filter within the vial at 65° C for 1-2 hours in an oven.

Add 10 ml of scintillation fluor (PFOjPOPOP with a toluene reagent base)
to each vial and count the vials for 10 minutes in a liquid
scintillation counter.
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scintillation counter. The scintillation fluor was composed of ^ gm
PPO and 0.05 gm POPOP dissolved in 1 liter of reagent grade toluene.
The scintillation fluor was usually allowed to stand overnight to
insure that the reagents were dissolved and then the fluor was stored
in a dark brown bottle until used.
The results from the blastogenesis cultures were reported in
counts per minute and are the average of triplicate cultures counted
twice.

The stimulatory index (S.I.) and culture counts (C.G.) were

determined for each test sample.

The S.I. was calculated by dividing

the counts per minute for PHA-P stimulated cultures by the counts per
minute for nonstimulated control cultures.

The C.C. were determined by

subtracting the nonstimulated culture counts per minute from the PHA-P
stimulated culture counts per minute.
Because the sample sizes were small and results were compared
between two groups of animals, statistical analysis of the data was
performed using the Mann-Whitney U test (69).

Two groups of animals

were considered to be significantly different if the probability
(p value) was equal to or less than 0.05.

Differential white blood cell counts
The slides prepared for differential WBC counts were stained by the
polychrome staining procedure as outlined in table 4. A total of
100 cells was counted and the cell types analyzed under oil immersion
to enable more accurate identification.

The cell types identified were

segmented and juvenile neutrophilic granulocytes, eosinophilic granulo
cytes, basophilic granulocytes, lymphocytes and monocytes (66).
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Table k

Staining procedure of blood smears prepared for differential
white blood cell counts

1.

Dip blood-smear slide into absolute methanol for one second.

2.

Dip slide into eosin stain for twenty seconds.

3.

Wash slide in distilled water.

4.

Dip slide into polychrome stain for twenty seconds.

5.

Wash in distilled water and air dry.

6.

Observe under oil immersion objective lens.
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The absolute number of lymphocytes per mm^ of peripheral blood (AL/mra^)
was calculated when possible.

This calculation was accomplished by

multiplying the WBC count by the percentage of lymphocytes for that
calf.

Washing of radioactive glassware
All glassware that came in contact with radioactive substances was
decontaminated by soaking in 2% solution of Isoclean (isolab) overnight.
The glassware was then rinsed three times in tap water prior to running
through standard laboratory washing procedures for tissue culture
glassware as followst
1.
2.
3.
k.

Place in dilute acid
Rinse three times in
Rinse three times in
Dry and sterilize in

(HCl) bath overnight.
tap water.
distilled water.
autoclave.

Chapter 3
RESULTS

Lymphocyte separation
Purified T-lymphocytes are desirable for measuring their capacity
to respond to mitotic stimuli.
lymphocytes were compared.

Three methods of obtaining purified

The separation of human and bovine

peripheral blood was analyzed by the following: (a) ficoll-diatrizoate (9), (b) gelatin (87), and liquid silicone oil (37).
(a) Ficoll-diatrizoate (FD) - FD was prepared by dissolving
9.84 gm of sodium diatrizoate in 30 ml of distilled water
(pH 7.3)•

To this solution an additional 72 ml of distilled

water was added followed by 6.28 gm of Ficoll.

The FD

(specific gravity 1.080) was then heat sterilized at 121° C
and 15 psi for 15 minutes. The sterile solution was stored in
a foil-covered container at 4° G.

Prior to the separation

procedures, FD was warmed to ambient room temperature of 24° C.
Heparinized peripheral blood was diluted 1:2 with 0.85% saline,
and 10 ml was carefully layered over 5 ml of FD.

The sample was

centrifuged with a swing head for 20 minutes with a force of
400 x G at ambient temperature.

Lymphocytes of human blood

aggregated at the interface and were removed with a Pasteur
pipette.

These cells were then washed three times with tissue

culture medium prior to suspension.
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However, in following the
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same protocol, the lymphocytes from bovine calf blood could not
be separated from the erythrocytes.

After centrifuging bovine

calf blood, the lymphocytes remained dispersed throughout the FD
with the erythrocytes.

Muscoplat et al. (49) reported that they

were able to separate adult bovine lymphocytes with FD at a specific
gravity of 1.080,

Even by varying the specific gravity of FD

above and below 1.080 as well as the force applied to the interface,
the separation of calf lymphocytes still could not be attained.
The reasons for the discrepancies were not established.

(b) Gelatin - Ten ml of heparinized peripheral blood was
mixed with an equal volume of 3% gelatin dissolved in TC 199
medium.

After standing at 37° C for one hour, human erythro

cytes collected at the bottom of the test tube and leukocytes
remained in suspension.

However, the same results could not be

obtained with bovine blood, which failed to separate even after
reducing the gelatin concentration to 2%, The erythrocytes
and leukocytes continued to remain in suspension.
(c) Liquid silicone - Heparinized bovine peripheral blood was
centrifuged at 2,500 rpm, and the buffy coat was removed along
with 2 to 3 ml of serum.

A 0.5 ml volume of liquid silicone,

specific gravity of 1.075» (Diffusion pump oil grade) was first
placed in the bottom of a 1-ml plastic centrifuge tube.

A

portion (l ml) of the leukocyte-rich buffy coat was then layered
carefully on top of the oil.

After centrifugation at 2,500

rmp for 15 minutes, the leukocytes were dispersed in the diffusion
oil, and the erythrocytes were pelleted in the bottom of the
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centrifuge tube.

The leukocytes were removed with a Pasteur

pipette, washed free of silicone with medium and suspended in
RPMI 1640. This method accomplished the separation of peripheral
bovine leukocytes from erythrocytes, but the cost of liquid silicone
was prohibitive for the large number of samples anticipated.

Comparison of blastogenesls between whole and separated peripheral blood
In view of the problems involved in preparing preparations of
bovine lymphocytes, an alternative culture technique to measure blastogenic activity of bovine lymphocytes in the presence of PHA was
desired.

Therefore, the use of nonseparated peripheral blood was

attempted (6, 49).

A comparison of the blastogenic response to PHA

of lymphocytes in cultures of whole human blood and of FD separated
peripheral lymphocytes was made.
Figure 3 shows the culture counts (C.C.), in log scale, for
nonseparated blood and FD separated cultures stimulated with PHA.

The

C.C. for separated lymphocytes was approximately four times higher than
that of the whole blood.

Because the concentration of leukocytes in

each group was maintained at 1 x 10^ WBC/ml, the higher C.C. with
separated blastogenesis cultures were not surprising since these
cultures contained a higher population of lymphocytes. The leukocyte
population of FD-treated blood is almost 95% lymphocytes (49) whereas,
the percentage of lymphocytes in normal peripheral human blood is
approximately one half the total leukocytes. This would suggest that
the C.C. shown using nonseparated whole blood in the blastogenic assays
was comparable to the C.C. obtained by using FD separated lymphocytes.
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Figure 3 Bar graph ropresenting a
comparison between the culture
counts from blastogenesls cultures
of stimulated lymphocytes in ficolldiatrizoated separated and whole
blood cultures.

j
j

Separated lymphocytes
cultures

Whole blood
cultures

2?
With the problems encountered in separation of peripheral bovine
calf lymphocytes, the above results demonstrated that with human
blood equivalent data could be attained using nonseparated peripheral
blood.

Therefore, whole blood blastogenesis cultures could be used as

an indication for stimulation of T-lymphocytes by PHA.

Selection of filter paper and scintillation fluor
The separation of residual radioactive thymidine in the culture
medium was essential to measure the amount of the isotope that had been
taken up by the cells during blastogenesis activity.

One of the most

common methods of attaining the separation is by filtration (?6),
through Millipore

ji membrane filter or Whatman GF/C filter paper.

The retention of radioactive materials by the two filter types was
compared by separating the blastogenesis cultures into two equal por
tions and filtering the appropriate samples through each of the filters.
Although both filter types were found to retain similar amounts of
radioactive materials, the Whatman GF/C filter paper was selected
because of availability and considerably lower cost.
The scintillation fluor was the PPOtPOPOP combination dissolved
in toluene indicated earlier, which had been suggested by New England
Nuclear.

Since the filter papers were dried prior to the addition of

the scintillation fluor, the addition of absolute methanol was avoided.

Determination of incubation period for blastogenesis cultures
To determine the optimal incubation time for the maximum thymi
dine uptake by stimulated bovine blood cultures, an incubation-time

experiment was performed.

Triplicate cultures of control and PHA-P

blastogenesis cultures from three "normal" calves were incubated
for periods of time varying from 24 hours to 144 hours.

The

tritiated thymidine was introduced into each culture 24 hours prior
to the termination of the incubation period.

At the end of each

incubation time period, the cultures were precipitated with trichloro
acetic acid and collected on filter papers, which were stored until
the entire group was ready for counting.

The scintillation fluor was

added to each vial immediately before the samples were all counted.
The raw data presented in table 5 shows that the highest S.I. and
G.C. were achieved when cultures were incubated for a total of 96 hours.
Therefore, since the maximum uptake of tritiated thymidine occurred
after 96 hours of incubation, this time interval was used throughout
the study.

Studies involving newborn calves
The selection of calves was made by Dr. J. K. Ward.

Hie criteria

used for the diagnosis of weak syndrome (WS) calves were as follows:
rough hair, slow to stand with stiff arthritic knee joints, failure to
nurse and a red muzzle.
None of the calves were moved to other locations to simplify the
study but were retained on their respective ranches to minimize any
stress that could aggravate the existing conditions.

When the syndrome

was diagnosed, a blood sample was taken and sent from Hamilton to
Missoula.

Unfortunately, under this system the samples were frequently

received six hours later.

It should be noted that the health of some
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Table 5

Calf
1

2

3

Tabulated data for Incubation period determination from
normal calf PHA stimulated blastogenesis cultures

Age (wks)
4

2

6

Total
incubation
time

No PHA
culture
counts

24

448(c)

48

694

72

PHA
culture
counts

S.I.(a)
2.9

841

12,776

18.4

12,082

415

17,682

42.6

17,267

96

409

19,982

48.9

19,573

120

458

339

0.7

-119

48

4006

17,463

4.4

13,457

72

383

16,245

42.4

15,862

96

253

25,610

101.2

25,357

120

224

20,109

89.9

19,885

144

302

29,971

99.2

29,669

48

573

6146

10.7

5573

72

477

13,861

29.0

13,384

96

1289(c)

G.C.(b)

No data available

120

316

8560

27.1

8244

144

193

3374

17.5

3181

(a) S.I. « stimulated culture counts/control culture counts
(b) G.G. = stimulated culture counts - control culture counts
(c) Each value expressed in counts per minute is the average of
triplicate cultures counted twice.

severely afflicted calves continued to deteriorate, often succumbing
within 48 hours even after the administration of thymosin.

The data

obtained from blastogenesis studies of these calves were not included
in the analysis. Since the incidence of WS calves is believed to be
very high in the Bitterroot Valley and the onset of the syndrome is
sometimes insidious, the normal calves were selected from another area.
There were instances in which "normal" appearing calves developed
the syndrome even up to three week after birth, but this did not
occur with any of the normal calves used in this study. The normal
calf blood was obtained from animals located two miles from Missoula.
Dr. E. M. Pruyn, a Missoula veterinarian, selected and drew the blood
samples from the normal calves.

Table 6 list the calves used in this

portion of the test of the therapeutic value.

Thymosin in 0.1 M

phosphate buffer was administered to WS calves after the initial blood
sample was drawn.
A table comparing the total WBC count of calves in this age group
is given in table 7. The average number of WBC for normal newborn
calves was 8763 and for WS calves of a comperable age, 6530.

The

WBC counts of normal calves used in this study are within the range for
calves less than one year old as established by Schalm (66), who reported
the average WBC count for Hereford calves to be 11,1^0 with a range of

5750 to 17,800. The average WBC count found in WS calves was in the low
range.
In view of the low respone of T-lymphocytes to stimulation observed
in perinatal calves by Osburn and co-workers (51), the T-cell blastogen
esis response of newborn "normal" calves was investigated.

Although
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Table 6 Pertinent information for newborn calves used in study

Owner

Identification
number

Carter

918

1 day

WS calf

Carter

81?

4 days

WS calf

Carter

W10

1 day

WS calf

Carter

904

1 day

WS calf

Ward

SD47

1 day

WS calf

Ward

W3

1 day

WS calf

Ward

1054

1 day

WS calf

Ward

K1324

3 days

WS calf

Pruyn

1

1 hour

Normal calf

Pruyn

2

10 hours

Normal calf

Pruyn

3

12 hours

Normal calf

Pruyn

4

1 day

Normal calf

Pruyn

5

1 day

Normal calf

Pruyn

6

4 days

Normal calf

Pruyn

7

7 days

Normal calf

Pruyn

8

8 days

Normal calf

Age

Comments

32

Table 7

Calf type

White blood cell counts of calves

Number of
animals

Age

Ave. counts/mm3

Range

Normal, newborn

8

0-10 days

8763

12,600 - 5800

Normal

5

1-2 months

89*4-6

10,930 - 6600

Normal

6

8-9 months

8767

11,400 - 7400

WS, newborn

8

0-10 days

7239

14,400 - 2200

WS

9

1-2 months

7010

11,740 - 4500

WS

8

8-9 months

7775

9200 - 6700
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the number of test animals was limited (a total of eight calves), the
T-cell response to PHA-P was low during the first hours postpartum.
The counts for control and stimulated cultures as well as S.I. and G.G.
for each calf is given in table 8.

When the S.I. is plotted in rela

tionship to age (figure 4), the T-cell population is depressed in
relation to stimulation with PHA-P during the first hours postpartum.
The ability to stimulate T-cells with PHA-P increased after 48 hours
to a level that was maintained up to 8 days.
The results of blastogenesis studies on newborn calves afflicted
with the weak calf syndrome is tabulated in table 9. The average S.I.
for newborn WS calves prior to injection of thymosin was 1.5 compared
to an average S.I. of 12.9 for newborn normal calves.

Following one

injection of thymosin (1000 jugra) in phosphate buffer, the average S.I.
of WS calves increased to 57-8.

However, this Increase is misleading

since the blood blastogenesis cultures for the WS calves given thymosin
were not prepared until two months after the first S.I. were determined.
A bar graph of the S.I. for each test group is presented in figure 5.
The G.G. for each test group are shown in the bar graph in figure 6.
The average C.C. for normal newborn calves was 404 cpm with a range
of -3 cpm to 853 cpm. The C.C. for WS calves prior to the administration
of thymosin ranged from -225 cpm to 522 cpm with an average G.G. of
101 cpm. After the administration of thymosin the G.G. for the same
WS calves rose to an average C.C. of 1233 cpm with a range of ?29 cpm
to 1722 cpm.
When comparing the newborn normal calf and WS calf, the S.I.
(p<,05) and C.C. (p<.05) are significantly different.

Since the data
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Table 8 Tabulated data for PHA stimulated blastogenesis cultures
for normal newborn calves

Calf

Age

No PHA
culture
counts

PHA
culture
counts

11(c)

8(c)

1

1 hour

2

10 hours

20

3

12 hours

4

S.I.(a)

G.C

0.7

-3

191

9.5

171

44

478

10.9

434

24 hours

150

1003

6.7

853

5

24 hours

14

388

27.7

374

6

4 days

24

442

18.4

418

7

7 days

38

600

15.8

562

8

8 days

34

453

13.3

419

(a) S.I. =* stimulated culture counts/control culture counts
(b) G.C. = stimulated culture counts - control culture counts
(c) Each value expressed in counts per minute is the average of
triplicate cultures counted twice.
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Figure 4 Scatter graph showing
the stimulatory index for PHA
stimulated blastogenesls cultures
of newborn normal calves
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Table 9 Tabulated data for PHA stimulated blastogenesis cultures for
WS calves prior to and after administration of thymosin

No PHA
culture
counts

Age

Calf

C.G.(b)

1.5

240

1176

0.8

-225

1 day

522

331

0.6

-191

1 day

1957

2479

1.3

522

1 day

492

730

1.5

238

4 days

¥10

Hard SD47

705(c)

S.I.(a)

1401

817

1

S

Prior to administration of thymosin
1 day
465(c)
Garter 918

PHA
culture
counts

"

W3

1 day

94

169

1.8

75

"

K1328

1 day

5

149

2.6

144

1 day

282

288

1.0

6

1749

64.8

1722

" 1054

After administration of thymosin (d)
Garter 918
2 months
27
2

"

12

1370

114.2

1358

" tflO

2

"

20

1610

80.5

1590

N

2

"

20

1370

68.5

1350

2

•

34

763

22.4

729

69

1035

15.1

966

817

(JQlf,

Ward SD47
"

W3

Not available

"

K1328

Not available

" 1054

2 months

(a) S.I. =•= stimulated culture counts/control culture counts
(b) C.C. » stimulated culture counts - control culture counts
(c) Each value expressed in counts per minute is the average of
triplicate cultures counted twice.
(d) The blastogenesis cultures for this portion of the study were not
performed until two months after the first cultures were done.
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Figure 5 Bar graph representing
the stimulatory index from blastogeneais cultures from PHA stimulated
cultures of newborn normal and WS
calves. Bar lines represent range.
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Figure 6 Bar graph representing
the culture counts from blastogenesls cultures of PHA stimulated
cultures of newborn normal and
WS calves. Bar lines represent
range.
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gathered, on treated WS calves was misleading, statistical comparison
of the treatment was not computed between

prior and after administration

of thymosin.

Studies involving calves 1-2 months old
In order to determine the effects of the thymic extract on chronic
WS calves, two test groups were selected from the same herd within
the Bitterroot Valley.

The first group consisted of calves 1-2

months old and the second group selected from the same calf crop
were 8-9 months old.

Mr. Van Meter, who ranches approximately twelve

miles south of Hamilton, allowed his herd to be used after the initial
arrangements were made by Dr. Ward.

The test calves were kept in an

open pasture with the other cattle belonging to the rancher.

All

animals were caught by Mr. Van Meter at the times the blood samples
were obtained.
Mr. Van Meter experienced a calf loss rate of approximately 2$%
in his herd during the spring of 1975.

Dr. Ward stated that this is

about the average loss rate for herds affected with the weak calf
syndrome for the first time in contrast to about 5 to 7% in herds
having experienced this condition previously.

The selection of calves

to be included in the "normal" and "WS" calf groups was made by Dr.
Ward using the same criteria stated previously.

A summary of the

calves used in this portion of the test is given in table 10.
The blood samples were drawn by Dr. Ward from the test calves.
With the blood collected on the initial visit, WBG count, differential
WBG count and bl&stogenesis studies were performed.

The results of these

Table 10

Owner

Pertinent information for calves 1-2 months old

Identification
Number

Age(days)

Comments

Van Meter

I8b

42

Normal, given thymo
sin in phosphate buffer

Van Meter

Y26

42

Normal, given thymo
sin in phosphate buffer

Van Meter

Y89

46

Normal, given thymo
sin in phosphate buffer

Van Meter

wyt-

39

Noxmal, given BSA

Van Meter

Y96

45

Normal, given BSA

Van Meter

*75

39

WS, given thymosin
in phosphate buffer

Van Meter

W89

29

WS, given thymosin
in phosphate buffer

Van Meter

Y1

62

WS, given thymosin
in phosphate buffer

Van Meter

Y121

21

WS, given thymosin
in phosphate buffer,
expired

Van Meter

Y66

22

WS, given thymosin
in phosphate buffer

Van Meter

Y103

35

WS, given thymosin
in peanut oil

Van Meter

W?8

33

WS, given thymosin
in peanut oil

Van Meter

W32

39

WS, given BSA

Van Meter

Y63

32

WS, given BSA

teats will be given later.

During this initial visit one injection of

(1000jugm/calf) in 0.1 M phosphate buffer, thymosin (1000 jugm/calf)
in peanut oil or BSA (1000^lgm/calf) in 0.1 M phosphate buffer was
administered.

The proper dose of each was given by intramuscular

injection into alternate normal and WS calves.

Neither Dr. Ward or

Mr. Van Meter was aware of which injection was given to a particular
calf.

The subsequent visit to the ranch was made one week later.

At that time a sample of blood was drawn from each test calf for
comparison studies.

During the week one calf, Y121, that had been

given thymosin in phosphate buffer expired.

Therefore, the results

of this calf were not included.
The average WBC counts for each group are given in table 7.

The

average WBG count for normal calves was 8946 compared to 7134 for the
WS animals.

After the administration of thymosin in phosphate buffer,

the average WBC count for WS calves was 7887 and 9717 for normal calves.
The average WBC count was 6800 for WS calves given thymosin in peanut
oil.

The values obtained during the initial visit are below the average

WBC counts of 11,400 for Hereford calves less than one year old (66)
but are within the range of 5750 to 17»800.

The differential counts,

table 11, for normal and WS calves showed little variation between
the groups in relation to percentages of lymphocytes and polymorphic
neutrophils.

The average percentage of lymphocytes was 77 for normal

calves and 70 for WS calves prior to the administration of an extract.
The average polymorphic neutrophils percentages were 16 and 23
respectively.

One week after the administration of thymosin in

phosphate buffer the lymphocytes and polymorphic neutrophils average
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Table 11

Differential WBC average counts for 1-2.month old calves

Group
Normal calves
Before admin.
After thymosin
After BSA
VS calves
Before admin.
After thymosin
in phosphate
buffer
After thymosin
in peanut oil
After BSA

Number

Neutrophils
Juvenile Segmented

Lymphocytes

Monocytes

5
3
2

^.2
1.0
1.5

12.2
35.3
12.5

76.6
77.0
84.5

7.0
3.6
2.0

7

^.0

18.8

69.6

3.8

4

2.3

28.9

61.2

6.3

2
1

4.5
1.0

21.5
15.0

?2.0
82.0

6.5
1.0

Normal values (66) 26
Range

23.7
12 - 38

68
12 - 80

3.2
1 - 5
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percentages for WS calves were 62 and 31 percent respectively ami 72
and 26 respectively for calves given thymosin in peanut oil.

One

of the two WS calves given BSA had a differential count of 22 percent
lymphocytes and 77 percent polymorhpic neutrophils.

The high percentage

of polymorhpic neutrophils indicates an infection, probably of bacterial
or protozoan etiology.

Therefore, the resutls for this calf were not

included. The other WS calf injected with BSA had 82 percent lympho
cytes and 16 percent polymorhpic neutrophils.
of lymphocytes is normal for cattle.

The high percentage

The values obtained are within

the range for lymphocytes of 42 and 80 percent with an average of
68 and for polymorhpic neutrophils the range is 12 to 38 percent
with an average of 23 percent (66).
The absolute number of lymphocytes per mm^ of peripheral blood
(AL/mnP) can be determined by multiplying the WBC count by the percentage

of lymphocytes. To determine if there is an increase in absolute
number of lymphocytes with the administration of thymosin, the AL/mm^
was determined for the calves of this test group.

The AL/mnP for

each test animal of normal and weak calf groups is tabulated in table
12. The average AL/mnP for normal calves and WS >calves was 6846
and 5072 repsectively.

There was a significant difference (p=..05)

between normal calf and WS calf groups prior to any administration
of test materials.
The average AL/mm

for those normal calves given thymosin increased

from 7318 to 7448 and for WS calves the average decreased from 4768
to 4759. The AL/mm^ dropped in two normal calves, W26 and Y89, and
in one WS calf, Y75.

For calves given thymosin in peanut oil, there
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Table 12 Tabulation of absolute lymphocytes per ram^ (AL/mm3) for
normal and WS calves 1-2 months old

Group

Calf

MBC count

% lymphocytes

Normal
Prior to any administration of thymosin or BSA
Y84
10,350
78
W26
8050
85
Y89
8800
80
W34
10,930
70
Y96
6600
70
After administration of thymosin in phosphate buffer
Y84
11,300
90
W26
7400
84
Y89
10,450
57
After administration of BSA
W34
8600
86
Y96
5600
83
Weak syndrome
Prior to administration of thymosin or BSA
Y75
11,7**0
61
W89
4800
77
Y1
6100
60
Y66
6800
67
Y103
8400
64
W78
3980
90
W32
8120
92
After administration of thymosin in phosphate buffer
Y75
7000
62
Y89
7050
66
Y1
9600
47
Y66
7900
70
After administration of thymosin in peanut oil
Y103
9000
60
Y?8
4600
84
After administration of BSA

W32

6900

82

AL/mm--

8073
6243
7040
7651
4620
10,170
6216
5957
7396
4648

7161
3696

3660
4556
5376
3582
7470
4340
^653
4512
5530
5400
3864

5658

^5
was an increase in the average AL/mm3 from 4479 to 4632.

The calves

of both groups given BSA showed a decrease in average kh/mrt?.

The

administration of thymosin did not increase the AL/mnP in WS calves
to a level where this group would not be significantly different
(p <.05) from the normal calves prior to treatment.
The blood collected during the initial visit was studied to
obtain the baseline value of blastogenesis.
are tabulated in table 13.

The results of these studies

Because of technical problems the blasto

genesis culture samples for the two calves, ¥78 and Y103, given thymosin
in peanut oil were not included.

The average S.I. shown in figure 7

for normal calves was 80.9 ranging from 59.5 to 92.7, whereas, the
WS calf average S.I. was 47.5 ranging from 23.1 to 57-6.

These data

indicate that there is a significant difference (p < .05) between the
S.I. of normal calves and WS calves prior to any administration of
test materials.

The S.I. for normal calf group after treatment shown

in figure 7 rose to 106 but the results from calf W34 and W26 were
disregarded; the low S.I. of 10 and 8 respectively for these calves
appeared to result from nonspecific stimulation of the T-cells of control
samples.

The two normal calves, Y84 and Y89, given thymosin in

phosphate buffer showed an average S.I. of 153.

This very high S.I.

resulted from the very low uptake of tritiated thymidine by the
lymphocytes of the control cultures.

The average S.I. for WS calves

indicated in figure 7 given thymosin was 55 with a range of 30.3 to
77.5.

The one WS calf given BSA showed a S.I. of 102, but the other

calf, Y63, was not included because of an apparent infection.

After

the WS calves were treated with tymosin, there was no significant
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Table 13

Group
Normal

Tabulated data for PHA stimulated blastogenesis cultures
for normal and WS 1-2 month old calves prior to and
after administration of thymosin or BSA

Calf

No PHA
culture
counts

PHA
culture
counts

S.I,(a)

Prior to administration of thymosin or BSA
Y84
45(c)
4168(c)
92.6
61
Y89
5811
95.9
W26
40
2359
59.5
W34
4268
56
74.2
82.1
Y96
65
5330
:administration of thymosin
Y84
69
5694
Y89
3030
37
W26
200
1539
After administration of BSA
¥34
181
Y96
20

1827
3056

5625
2993
1339

10.1

1746

152.8

3036

After administration of thymosin
Y?5
94
2844
30.3
W89
98
4494
45.8
Y1
21
1628
77.5
Y66
38
2586
68.1
Y121
Calf expired during the study

5798

4123
5750
2319
4212
5265

82.5
81.2
7.7

Weak syndrome Prior to administration of thymosin or BSA
Y75
126
7229
57.3
W89
285
6607
23.1
Y1
38
2077
55.^
Y66
105
4054
38.5
Y121
18
977
53
W32
81
4660
57.6

After administration of BSA
W32
57

G.G.(b)

101.7

7103

6322
2039
3949
959
4579

2750
4396
1607
2548

5741

(a) S.I. = stimulated culture counts/control culture counts
(b) G.G. = stimulated culture counts - control culture counts
(c) Each value expressed in counts per minute is the average of
triplicate cultures counted twice.
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Figure 7 Bar graph representing the
S.I. from blastogenesis cultures of
PHA stimulated cultures of 1-2 months
old normal and WS calves prior to and
after administration of thymosin.
Bar lines represent range.
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difference (p"> .05) between the S.I. of this group and the S.I. of
normal calves prior to any treatment.

There was no significant differ

ence (p >.05) between the S.I. of normal and VfS calves after adminis
tration of thymosin.

However, the data of calf W32 was not considered

and the S.I. for the remaining two calves was higher than the S.I.
of any weak calf.

Because of the small sample size for calves

treated with BSA, statistical analysis could not be computed.
There was adequate uptake of tritiated thymidine by PHA-P
stimulated lymphocytes shown by the fact that most cultures had around
2000 cpm. The average G.G. for normal calves indicated by the bar
graph in figure 8 was 4334 cpm with a range of 2319 cpm to 5750 cpm.
The WS calf average G.G. was 4159 with a range of 959 cpm to ?103
cpm.

Using the Mann-Vhitney statistical analysis, there was no

significant difference between the two groups of test animals. The
C.G. for the two normal calves, Y84 and Y89, after administration of
thymosin in phosphate buffer was 4308 cpm.
given BSA measured 3036 cpm.

The G.G. of calf Y96

The MS calves given thymosin in phosphate

buffer exhibited an average G.G. of 2825 cpm with a range of 1607
cpm to 4396 cpm, and the calf W32 given BSA exhibited a G.C. of 5?4l.

Studies Involving calves 8-9 months old
The effect of thymosin on 8-9 month old calves was tested in order
to establish an understanding of the effect of thymosin in older
calves.

The animals were selected from Mr. Van Meter's herd.

Care

was taken to select calves about the same age and not to include
calves previously used.

Although the date of birth for each calf

Figure 8 Bar graph representing the
culture counts from blastogenesis
cultures of PHA stimulated cultures of
1-2 month old normal and VS calves
prior to and after administration of
thymosin. Bar lines represent range.
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could not be established, the calves were all born in February and
March 1975 and were, therefore, 8 to 9 months old when tested.
calves were kept separated from the herd and fed daily.

The

The blood

was drawn by Dr. lifard while the calves were held in a squeeze chute.
The administration of test materials was done by intramuscular
injection while the calves were in the chute. The selection of calves
shown in table 1^ was made by Dr. Ward using the criteria outlined
previously.

A total of six "normal" calves and eight "weak syndrome"

calves was included in the testing.

To show the significant differ

ence between the size of normal and WS calves, the calves were weighed.
The weight for normal calves ranged from ^10 pounds to 530 pounds with
and average weight of 4-50 pounds, whereas, the average weight of WS
calves was 236 pounds with a range from 185 to 275 pounds. There was
a significant difference (p <^.05) between the two groups of aminals.
The schedule and dose of injected materials were changed from
previous tests.

An injection of BSA (20,000^ugm/calf) was administered

after the initial blood sample was drawn.

The second blood sample

was drawn a week later as well as the administration of thymosin
(20,000 jugm/calf) in 0.1 M phosphate buffer to each calf.
later the final blood sample was collected.

One week

With each blood sample

collected, WBC count, differential WBG counts and blastogenesis studies
were completed.
Table 7 shows the average WBC count obtained for each group of
calves during the initial visit. The average WBG count and range for
normal and WS calves was 8767 (7^00 - 11,^0) and 7775 (6700 - 9200)
respectively.

The average WBG count for normal calves increased to
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Table 14 Pertinent information for calves 8-9 months old

Owner

Identification
number

Weight

Comments

Van Meter

R62

430

Normal calf

Van Meter

R43

530

Normal calf

Van Meter

R84

410

Normal calf

Van Meter

W?

455

Normal calf

Van Meter

W127

450

Normal calf

Van Meter

Y106

425

Normal calf

Van Meter

39401

225

WS calf

Van Meter

W38

205

WS calf

Van Meter

Wl8

2?5

WS calf

Van Meter

W108

265

WS calf

Van Meter

W120

185

WS calf

Van Meter

Will

260

WS calf

Van Meter

Y119

250

WS calf

Van Meter

Y46

220

WS calf
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9232 (7300 - 11,200) after the administration of BSA and to 896?
(?200 - 12,600) after the administration of thymosin.

For WS calves

the average WBC count after the injection of BSA decreased to 7538
(6300 - 8900) and after thymosin increased to 8571 (5700 - 9800).
The differential showed that the distribution of polymorphic neutro
phils and lymphocytes was similar in both test groups.

There was no

significant increase in the percentage of lymphocytes after administra
tion of BSA or thymosin.

The data is summarzied in table 15.

The absolute lymphocyte number per mm^ of peripheral blood (AL/mirP)
was determined as previously stated.
tabulated in table 16.

The data for each animal is

The average and range for normal calves was

6898 (5328 - 8778) AL/mrP prior to any injection of test materials.
The average increased, for normal calves after BSA administration
7570 (5986 -

10,192) AL/nuP } after thymosin administration the

average AL/mnP was 7071 (6192 - 8820). There was in increase in AL/nmP
in WS calf average to 6181 (4810 - 8064).

Prior to the administration

of BSA, there was a significant difference (p <.05) between AL/mm^ for
normal and WS calves.

However, after BSA administration there was

no significant difference (p<.10) as was also seen after administra
tion of thymosin (p> .10), and the probability factor (p factor) was
larger after administration of thymosin than after administration
of BSA.
Technical problems with the incubation system for blastogenesis
caused the data obtained to be disregarded.

Although blastogenesis

cultures were established, there was too much variability in the
results obtained for the results to be useful.
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Table 15

Differential HBC average counts for 8-9 month old calves

Group

Nuaber

Neutrophils
Juvenile Segmented.

Lymphocytes

Monocytes

Normal calves
Before admin.
After BSA
After thymosin

6
6
6

2.8
1.2
1.3

10.7
10.5
11.5

78.7
81.8
80.0

*K3
2.5
3.6

YS calves
Before admin.
After BSA
After thymosin

8
8
7

3.6
2.5
3.0

15.3
11.0
1^.1

72.5
81.5
7^.0

5.9
2.3
5.0
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Table 16

Tabulation of absolute lymphocytes per mm3 (AL/mm3) for
normal and WS calves 8-9 months old

Group
Normal

Calf

WBC count

Prior to administration of BSA
R62
11,400
H43
9800
R84
8000

¥7

8000

W12?
7400
Y106
8000
After BSA administration
R62
11,100
R43
11,200
R84
9500
*7
7700
¥127
8600
Y106
7300
After thymosin administration
R62
12,600
R43
9000
R84
8600
¥7
7300
¥127
7200

Y106

9100

% lymphocytes

7?
80
77

AL/mm3

8778
7840
6l60

82

6560

72
84

5328
6720

79
91
81

8769
10,192
7695

85

6545

73
82

6278
5986

70
74
83
88
86

8820
6600
7138
6424
6192
7189
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Weak syndrome

Prior to administration of BSA
S9401
9200
67
W38
6700
81
¥18
7100
71
¥108
8100
81
¥120
6700
66
¥111
8300
69
Y119
8800
64
Y46
7300
81
After BSA administration
80
S9401
8600
¥38
6300
80
¥18
6500
74
¥108
8400
96
¥120
7300
75
¥111
8900
73
86
¥119
7700
Y46
6600
88
After thymosin administration
S9401
8200
82

6l64
5427
5041

6561
4422
572?

5632
5913
6880
5040
4810
8064
5475
6497

6622
5808
6724

¥18

6500
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3835

¥108
¥120
¥111
¥119
Y46
¥38

9200
7600
9200
9500
9800
5700

77
62
72
78
88
Not available

7084
4712
6624
7410
8624

Chapter 4
DISCUSSION

Selection of calves
Since the University of Montana does not have a bovine test herd
or facilities for housing large animals, this study had to be done
with calves on the owner's ranches within the Bltterroot Valley.

Dr.

Ward made the initial arrangements with the ranchers to allow their
calves to be used in these experiments.

Although inherent problems were

encountered, these arrangements were necessary to obtain any data.
By using a group of animals fifty miles from the laboratory,
however, transportation of samples created a major problem.

The blood

samples requently arrived at the laboratory six hours after collection.
On several occasions the samples were received on the following day
after being drawn. To add to the complication, these samples were left
either in a cooler in the truck used by Dr. Ward or in the clinic at
unknown temperatures until transported to the laboratory. The vari
ability of some of the data could have been due to these conditions.
The most ideal situation was to be present when the blood samples
were drawn as was done during the bleeding of one-month and older
calves.

However, samples from newborn weak syndrome(WS) calves were

another matter since the birth of such calves could not be predicted.
Dr. Ward drew blood from these diseased animals only when the oppor
tunity arose.
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Calves are obviously of economic value to the rancher, but the
depressed cattle market decreased the attempts of many ranchers to
save animals with severe afflictions.

In the case of the WS calves,

the problem was magnified since previous therapy with whole immune
serum that had "saved" numerous calves did not alleviate the runting
condition associated with the syndrome.

Therefore, weight gain of

normal calves was approximately 100# greater after one year that in
VS calves. Since the runted animals consumed almost as much feed as
the normal ones, the financial return was considerably less.

In view

of the above conditions, the rancher was reluctant to incur the addi
tional expense of procuring the services of a veterinarian.

Since

Dr. Ward was depended upon to collect the materials from the diseased
animals, samples became increasingly difficult to obtain.
The pool of available calves that could be used was further
reduced since calves from previous herds given thymosin or passive
immune therapy were not suitable for the study of chronic calves.
Thymosin had been administered to a number of animals during the
spring of 197^. Thymosin and passive immune therapy was given to
a large population of calves belonging to several ranchers who had
been particularly cooperative during the studies of the WS calf by
this laboratory.

Therefore, herd animals without previous exposure

to thymosin or immune serum was desired, but locating these types of
herds was difficult.
Just prior to the spring of 197^» Mr. Van Meter moved into the
valley from eastern Montana.

He brought several head of cattle from

elsewhere and purchased cattle from other ranchers in the Bitterroot
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area to establish his herd.

Not aware of the disease problem

prevalent in the area, he was perplexed during the first year when
his pregnant heifers began to abort or give birth to calves unable to
stand and nurse.

After losing a large number of his calf crop the

first year, Mr. Van Meter contacted Dr. Ward who diagnosed the
problem as the weak calf syndrome. The next spring, 1975• Mr. Van
Meter lost 23% of his calf crop.

When he learned of our interest

in conducting studies with thymosin using a herd not previously
exposed to any test materials, he expressed his desire to provide the
necessary animals from his herd for our limited studies.
During the testing of thymosin on calves under one month of age,
there was a tendency to treat all WS calves with thymosin and not to
include control animals injected with a placebo.

Since the adminis

tration of thymosin to some calves during the spring of 197^ resulted
in dramatic improvements, the ranchers understandably desired to
treat all, including normal, calves with thymosin.

The desired

procedure was to use one herd to test all materials, a situation
provided by Mr. Van Meter.

Since neither the rancher nor Dr. Ward

was aware of which injections each calf received, proper control
measures were maintained.
Scheduling of the bleeding and administration of test materials
were made by Dr. Ward, Since young calves were still nursing, all
animals were retained with the herd during the study.

The arrangement

had its difficulties in that the calves desired for bleeding or injec
tion were intermingled with the other non-testing cattle. Therefore,
in addition to sorting the test animals, reliance had to be upon
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Mr. Van Meter to rope the calves.
Older calves did not create as much difficulty in that they were
corralled and kept separate from the herd.

This arrangement was more

suitable since less help was needed and the collection time was
reduced, but Mr. Van Meter also absorbed the additional expense of
feeding these animals for the three-week period.
On occasion the scheduling of all the persons necessary for the
bleeding and injections was difficult to coordinate.

For example,

the time intervals required for bleeding and injection of animals
could not always be coordinated, and delays were the frequent conse
quences.

The blastogenesis assays for newborn WS calves given thymosin

should have been performed within two weeks after the injection instead
of two months later.

Visual observation of thymosin therapy
Although the serum therapy used previously was undoubtedly
responsible for the survival of numerous diseased calves, their general
health did not necessarily improve.

The calves were susceptible to

secondary infections especially those leading to scours.

Although the

treated calves were frequently able to stand and to nurse, several of
these animals had to be bottle fed or had to have their heads held
while nursing,

Even six months later when lymph node excision was done

on two of these animals, the lesions required over a month to heal
whereas, the lesions due to lymph node excision in normal calves
healed within b8 hours.
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Since immune serum was tedious to prepare and, as stated earlier,
the WS calves showed thymic atrophy and involution, the administration
of thymosin was attempted.

With three injections of thymosin (1000 pgm

each) on alternate days dramatic improvements were observed.

An example

of the observations made by Dr, Ward following this schedule of
injections during preliminary studies during the spring 197^ is
as follows:
day of 1st injections
day of 2nd injections
day of 3rd injections

calf docile, unable to nurse or stand,
typical WS calf
calf able to stand, began to nurse,
increased mobility since able to walk
calf nursed vigorously, can not be
approached, had to be roped to administer
the injection, running with increased
agility

After thymosin administration, calf scours were either reduced or
controlled, particularly upon continued therapy.
As stated above the general health of most WS calves improved
within a couple days after the first injection.

The rapid improvement

seen when the WS calves were given thymosin suggested that the agent
does more than reconstitute the T-cell mediated immune functions.
Although the immunocompete peripheral T-cells increased with thymosin,
an effect upon the horraaaal balance of WS calves is suggested in view
of the dramatic and rapid improvement observed. The thymus had been
implicated as affecting the production of growth hormone and thyroxine

(.57)*

With injection of thymosin the production and utilization of

these and other hormones could have been stimulated in the WS calves.
If the thymus is involved in regulation of growth hormone and thyroxine
in calves, then the administration of thymosin could reverse the runting
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syndrome of WS calves and result In more rapid weight gain.

Beneficial

effects in normal calves such as increased weight gain per pound of
feed may also occur.

Further investigation over several years would

be required to establish the validity of this hypothesis.

However,

the improvement of WS calves had regressed in some animals after one
week if only one injection of thymosin was administered.

The regres

sion of improved health observed when thymosin injections were not
continued gives further support to the hypothesis that the thymus
has a hormonal function, at least in calves.
Several calves severely afflicted still died even after thymosin
was administered.

The condition of these animals had deteriorated

beyond the point that therapy was unavailable.

On the other hand,

whether more concentrated and frequent injections of thymosin could
have improved the prognosis of these types of calves is speculative.

Blastogenesis study
The mitogen, phytohemagglutinin (PHA), induces T-cells to undergo
blast-like transformation.

The stimulation can be measured by the

uptake of tritiated thymidine during mitosis and can be used as a
basis for evaluating the population of immunocompetent T-cells in the
peripheral blood.

Since the thymus of WS calves has been shown to be

involuted (53)» the response of the peripheral T-cells to PHA stimulation
was used as an index of the status of the cellular immune system.
A summary of the blastogenesis data is given in table 1?.

Newborn

normal calves have a lower or depressed response as compaxed to calves
1-2 months old. A statistically significant difference (p<.05) was

6l

Table 1? Summary of S.I. and. G.C. data for normal and WS newborn
and 1-2 month old calves

Calf group

Number
calves

Average
S.I, (a)

Average
C.C. (b)

Normal, newborn

8

12.9

bob

Normal, 1-2 months old
After thymosin (c)
After BSA

5
2
1

80.9
81.9

4334

152.8

4309
3036

Weak syndrome, newborn

8

1.5

101

Weak syndrome, 1-2 months old
After thymosin (c)
After BSA
Thymosin at birth (d)

6

^7.5

*H58

k

55A

1
6

101.7
60.9

2852
2118
1319

(a) S.I. = stimulated culture counts/control culture counts
b) G.C. «= stimulated culture counts - control culture counts
c) Thymosin and BSA (1000 jxgm/injection) were given one week prior
to the blood samples being taken.
(d) Calves of this test group were given thymosin (1000 }igm) at
birth. Blood samples were taken when the calves were 2 months old.
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measured when the data was analyzed by the Mann-Whitney U test.

The

depression was also noted when the mitogenic response of newborn WS
calves was compared to 1-2 month old WS calves.

The generalized

depression observed in newborn animals could be a result of the high
concentration of corticosteriods reported to be present in the
circulatory system of fetuses prior to parturition (51).
The S.I. and G.G. calculated from the mitogenic response data
of newborn normal calves were significantly different from that of
newborn WS calves.

Although no significant difference was measured in

the C.G. between the two groups of 1-2 month old calves, a difference
was noted in calculating the S.I. data.

The results show that suppres

sed peripheral T-cell population is an indication of involuted thymuses
in WS calves.

The involution could be the result of a direct invasion

of the organ by an infectious agent or a stress response induced by
the infectious process.

In any case, susceptibility of these animals

to secondary infections was no doubt increased by the involution and
depressed peripheral T-cell population.
The competence of the cell-mediated immune system is routinely
determined by the ability of sensitized animals to elicit a delayed
hypersensitivity (DH) reaction to skin test antigens. In cattle a
DH reaction to protein derivative of tuberculin in animals naturally
infected with Mycobacterium bovis or given the BGG strain of M. bovis
requires a dose of 400 tuberculin units.
of 5 tuberculin units is used in man.

In contrast, the maximum

A DH reaction could not be

elicited in WS calves even though several injections of BGG had been
administered previously.

With failure to elicit a DH reaction, the WS
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calves were thought to be depleted of Immunocompetent T-cells,

However,

the results from calves tested at the Van Meter ranch indicated the
presence of T-cells responding to PHA stimulation in chronic WS calves.
Therefore, the chronic WS calves do have immunocompetent T-cells
although this population is depressed.
After the administration of thymosin the average S.I. of 1-2
month old WS calves, as shown in table 17, increased.

When compared

to the S.I. of normal calves prior to treatment, the increased S.I.
for WS calves was not significantly different (p>.05). There was also
no significant difference between the S.I. of normal and WS calves after
the administration of thymosin. It should be kept in mind that the
normal group consisted of only two calves, which obviously make the
comparison of the data questionable.

Since no significant difference

was noted between the WS group after treatment and the normal group
prior to treatment with thymosin, the results indicate that thymosin
induced mature immunocompetent T-cells to appear in the peripheral
blood circulation of WS calves.

Two mechanisms could be responsible

for this increase in immunocompetent T-cells.

However, it is not

possible to distinguish if the increase was caused by a release of
mature T-cells from the thymus or if thymosin actually induced the
maturation of T-cells in the circulating blood.

The fact that thymosin

has been shown to restore cell-mediated immunity to neonatal thymectomized mice (42) would seem to indicate that the latter hypothesis is
appropiate.
As newborn WS calves given thymosin were approximately two months
old before the second blastogenesis study was completed, this group

6^
can be compared to calves tested at the Van Meter ranch.

The Mann-

Vfhitney U test showed no significant difference between the S.I. of
newborn WS calves given thymosin immediately after birth and normal
or WS calves 1-2 months old prior to treatment.

The observation

indicated that thymosin administration did induce a mature T-cell
population in these newborn calves, but one injection of 1000 ^igm
was inadequate to increase the level of response to that seen in
normal calves.

Based on these results, the therapy should include

more concentration of the preparation and increased frequency of
treatment.

Some of the technical problems encountered during the blastogenesis study included the incubation temperature and variability of
the amount of radioactive thymidine uptake. When the incubation
temperature of the lymphocyte cultures was increased to 39° C, blast
like transformation of the cells in the presence of PHA could not be
measured. During the blastogenesis studies of 8-9 month old calves,
the incubator failed to operate properly. The temperature of over
39° C was noted in the incubator.

Variability of thymidine uptake by

"stimulated" lymphocytes was observed. At times a ten-fold difference
was recorded between triplicate cultures of the same test sample, and
these counts were not used in the calculations. Since the concentration
of PHA used was in the high range, some of the variability could be
attributed to the high concentration of PHA (23).

Effects of thymosin on lymphocyte numbers
To determine the effects of thymosin administration on the number
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of lymphocytes per volume of blood, an absolute lymphocyte number
analysis was performed using two groups of chronic calves at the
Van Meter ranch.

The first group consisted of 1-2 month old calves

and were also used in the blastogenesis study.

The second group of

calves 8-9 months old was selected from Van Meter's spring 1975

calf

crop seven months later.
The absolute lymphocytes number per mm^ of peripheral blood (AL/miiP)
for both age groups showed a significant difference between normal and
WS calves prior to any injection of thymosin.

After thymosin was

administered to 1-2 month old calves an increase in the AL/mm3 was
observed.

This increase in AL/mm^ was also noted in most normal 8-9

month old calves given BSA, but a decrease in AL/ranP was observed for
8-9 month old WS calves when administered BSA.

With the administration

of thymosin the AL/mm^ increased in most calves, but some showed a
decrease in AL/mm3,
The increase of AL/mm3 was only about 100 lymphocytes in most
cases after injection of either BSA or thymosin.

The small increase

could possibly be attributed to differences in the differential. The
difference would be magnified since the lymphocyte count was multiplied
by the total WBC count.

Brown (ll) stated that there could be a 10-15%

difference in the cell counts when performing the differential WBC
count.

Therefore, the small increase of 100 lymphocytes does not

seem sufficiently large to account for the increase in S.I, noted after
injection of thymosin in the 1-2 month old WS calves.

This would

tend to support the hypothesis that thymosin causes the maturation
of T-cells in peripheral blood rather than the release of mature
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T-cells from the thymus.

At the present time sufficient data is

not available to support either mechanism.
The rosette formation by peripheral lymphocytes has been used
to assay the T-cell population of peripheral blood (78).

In a

human patient there had been reported an increase in the number of
lymphocytes as well as an increase in the percentage of T-cell rosettes
with thymosin injections (77). This assay system could not be
performed during the course of the study on WS calves because of the
problems encountered when lymphocytes were separated from erythrocytes.
When the separation and purification of bovine calf peripheral
lymphocytes can be perfected, the rosette formation would probably
be a more effective means of ascertaining whether the administration
of thymosin increased the circulating peripheral T-cells.

Chapter 5
SUMMARY

Upon study of the calf afflicted with the weak calf syndrome, the
absence of a normal thymus development was observed.

It was also

observed that weak syndrome calves could not elicit a delayed
hypersensitivity skin reaction to purified protein derivative of
tuberculin even after repeated injection of Mycobacterium bovis
strain BCG.

The absence of delayed hypersensitivity was hypothesised

to be a result of a depressed or absent thymic lymphocyte (T-cell)
population.

Since neonatal thymectomized mice given thymosin were

able to reconstitute a functional T-cell population, thymosin was
believed to have a similar effect on weak syndrome calves.

More

specifically, the immunocompetence of the peripheral T-cell
population in weak syndrome calves was monitored to determine if
administration of thymosin reconstituted the T-cell population.

The

immunocompetence of the peripheral T-cell population in weak syndrome
and normal calves was determined before administration of thymosin.
Uptake of tritiated thymidine by phytohemagglutinin(PHA) was used to
monitor the immunocompetence of the peripheral T-cell population.

This

type of assay measures the stimulatory effect of the non-specific
mitogen PHA on the T-cell population which can be used to determine the
immunocompetence of this lymphocyte population.

Whole blood was used

for the blastogenesis cultures since the physical separation of
peripheral lymphocytes could not be attained in calf peripheral
6?
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"blood samples.

The immunocompetence of the T-cell population was

determined prior to and after one injection of thymosin (lOOO^igm).
Both weak syndrome and normal calves of varying ages were used.

To

determine if thymosin would Increase the number of lymphocytes in the
peripheral blood total and differential WBC counts were performed
at the time blastogenesis cultures were done.
It was determined that the T-cells from weak syndrome calves would
take up a significantly lower amount of radioactive thymidine than the
T-cells from normal calves.

After administration of thymosin there

was no significant difference in the amount of tritiated thymidine
uptake between the T-cells from both calf groups.

Any increase in the

total lymphocytes after thymosin was not large enough to account for
the increased stimulatory effect seen in T-cells from weak syndrome
calves.

Therefore, it was hypothesised that thymosin induced the matura

tion of peripheral T-cells in weak syndrome calves.

An added effect

of administration of thymosin which was not fully understood was the
very rapid improvement in the general health of weak syndrome calves
after one injection of thymosin.
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